Study of Safety and Efficacy of MY008211A in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor Therapy
Clinical trial NCT06932744 · RECRUITING
Trial details
- NCT number
- NCT06932744
- Sponsor
- Wuhan Createrna Science and Technology Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-30
- Primary completion
- 2025-12-30
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.